Management of Sedation with Valproate

Assessment and Initial Management

The National Comprehensive Cancer Network recommends determining if sedation is due to valproate therapy or other causes, such as other sedating medications, sleep disorders, or underlying medical conditions 1
Evaluate the severity of sedation and its impact on the patient's daily functioning and quality of life, as recommended by the National Comprehensive Cancer Network 2

For patients who require daytime alertness and cannot tolerate sedation, consider adding a psychostimulant such as methylphenidate or modafinil, or caffeine in the morning, as suggested by the National Comprehensive Cancer Network 1
These interventions should be used cautiously and only when necessary, according to the National Comprehensive Cancer Network 3

Patients with cognitive impairment may experience worsened confusion with sedating medications, as noted by the National Comprehensive Cancer Network 1
Avoid combining valproate with other sedating medications, especially benzodiazepines, as this increases the risk of excessive sedation, as warned by the National Comprehensive Cancer Network 3

Regularly assess the patient's level of sedation using standardized tools when available, as recommended by Critical Care Medicine 4
Monitor for signs of excessive sedation, which may precede respiratory depression in vulnerable patients, as cautioned by the National Comprehensive Cancer Network 3
Patients should be advised not to drive or operate heavy machinery if experiencing significant sedation, as advised by the National Comprehensive Cancer Network 2